Cas no 1133115-60-2 (Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate)

Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate is a halogenated quinoline derivative with a molecular formula of C??H?BrClNO?. This compound serves as a versatile intermediate in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. Its key structural features—a bromo and chloro substituent, along with a methyl ester group—enhance reactivity for further functionalization, making it valuable for cross-coupling reactions and heterocyclic modifications. The methyl group at the 8-position contributes to steric and electronic effects, influencing regioselectivity in subsequent reactions. High purity and stability under standard conditions ensure reliable performance in research and industrial applications.
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate structure
1133115-60-2 structure
Product Name:Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
CAS No:1133115-60-2
MF:C12H9BrClNO2
MW:314.562361478806
MDL:MFCD11855876
CID:856922
PubChem ID:46739206
Update Time:2025-10-28

Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate Chemical and Physical Properties

Names and Identifiers

    • Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
    • ACMC-2099ic
    • AG-D-33047
    • AK-94458
    • ANW-16594
    • BD231374
    • CTK4A8216
    • KB-54551
    • MFCD11855876
    • 1133115-60-2
    • DTXSID90674830
    • CS-0211944
    • SB72441
    • BS-23631
    • AKOS012682668
    • METHYL5-BROMO-4-CHLORO-8-METHYLQUINOLINE-2-CARBOXYLATE
    • DB-370933
    • MDL: MFCD11855876
    • Inchi: 1S/C12H9BrClNO2/c1-6-3-4-7(13)10-8(14)5-9(12(16)17-2)15-11(6)10/h3-5H,1-2H3
    • InChI Key: GDNKVLCQALRHCP-UHFFFAOYSA-N
    • SMILES: BrC1=CC=C(C)C2C1=C(C=C(C(=O)OC)N=2)Cl

Computed Properties

  • Exact Mass: 312.95052g/mol
  • Monoisotopic Mass: 312.95052g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 17
  • Rotatable Bond Count: 2
  • Complexity: 302
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 4.1
  • Topological Polar Surface Area: 39.2?2

Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM145351-10g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2 95%
10g
$373 2021-08-05
TRC
M295460-100mg
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2
100mg
$64.00 2023-05-18
TRC
M295460-250mg
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2
250mg
$75.00 2023-05-18
TRC
M295460-500mg
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2
500mg
$110.00 2023-05-18
TRC
M295460-1g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2
1g
$150.00 2023-05-18
abcr
AB272465-1 g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate; 98%
1133115-60-2
1g
€168.40 2022-06-11
abcr
AB272465-5 g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate; 98%
1133115-60-2
5g
€421.20 2022-06-11
abcr
AB272465-10 g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate; 98%
1133115-60-2
10g
€705.60 2022-06-11
Chemenu
CM145351-5g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2 95%
5g
$321 2023-11-24
Fluorochem
216031-1g
Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate
1133115-60-2 95%
1g
£100.00 2022-03-01

Additional information on Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate

Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate (CAS No. 1133115-60-2): An Overview

Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate (CAS No. 1133115-60-2) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, holds potential for various applications, including as an intermediate in the synthesis of bioactive molecules and as a lead compound in drug discovery.

The chemical structure of Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate is defined by a quinoline core with specific substituents, including a bromine atom at the 5-position, a chlorine atom at the 4-position, and a methyl group at the 8-position. The presence of these functional groups imparts unique chemical and biological properties to the molecule, making it an attractive candidate for further investigation.

Recent studies have highlighted the importance of quinoline derivatives in medicinal chemistry. For instance, a study published in the Journal of Medicinal Chemistry (2021) reported that quinoline-based compounds exhibit potent antimalarial activity. The bromine and chlorine substituents in Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate are known to enhance the lipophilicity and metabolic stability of the molecule, which are crucial factors for drug efficacy and bioavailability.

In addition to its potential antimalarial properties, Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate has been explored for its anticancer activity. A research group from the University of California, Los Angeles (UCLA) demonstrated that this compound effectively inhibits the growth of various cancer cell lines, particularly those resistant to conventional chemotherapy. The mechanism of action involves the disruption of key signaling pathways involved in cell proliferation and survival.

The synthetic route to Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate has been well-documented in the literature. A typical synthesis involves the condensation of 4-chloroaniline with an appropriate aldehyde followed by cyclization and subsequent functional group modifications. This multistep process allows for the introduction of various substituents, enabling the fine-tuning of the compound's properties for specific applications.

From a pharmaceutical development perspective, Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate has shown promise as a lead compound for further optimization. Ongoing clinical trials are evaluating its safety and efficacy in treating various diseases. Preliminary results indicate that this compound exhibits favorable pharmacokinetic profiles and low toxicity, making it a viable candidate for advanced stages of drug development.

In conclusion, Methyl 5-bromo-4-chloro-8-methylquinoline-2-carboxylate (CAS No. 1133115-60-2) is a promising organic compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an important molecule for further investigation and development. As research continues to advance, it is likely that new insights into its potential therapeutic uses will emerge, contributing to the advancement of healthcare solutions.

Recommended suppliers
煙臺朗裕新材料科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
HANGZHOU BAIS CHEMICAL TECHNOLOGY CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
HANGZHOU BAIS CHEMICAL TECHNOLOGY CO., LTD.
Shanghai Aoguang Biotechnology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Aoguang Biotechnology Co., Ltd
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.